Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 63

1.

Decrease of blood anti-α1,3 Galactose Abs levels in multiple sclerosis (MS) and clinically isolated syndrome (CIS) patients.

Le Berre L, Rousse J, Gourraud PA, Imbert-Marcille BM, Salama A, Evanno G, Semana G, Nicot A, Dugast E, Guérif P, Adjaoud C, Freour T, Brouard S, Agbalika F, Marignier R, Brassat D, Laplaud DA, Drouet E, Van Pesch V, Soulillou JP.

Clin Immunol. 2017 Jul;180:128-135. doi: 10.1016/j.clim.2017.05.006. Epub 2017 May 18.

2.

Intrathecal EBV antibodies are part of the polyspecific immune response in multiple sclerosis.

Otto C, Oltmann A, Stein A, Frenzel K, Schroeter J, Habbel P, Gärtner B, Hofmann J, Ruprecht K.

Neurology. 2011 Apr 12;76(15):1316-21. doi: 10.1212/WNL.0b013e318215286d. Erratum in: Neurology. 2013 Mar 12;80(11):1069.

PMID:
21482946
4.

Temporal relationship between elevation of epstein-barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis.

Levin LI, Munger KL, Rubertone MV, Peck CA, Lennette ET, Spiegelman D, Ascherio A.

JAMA. 2005 May 25;293(20):2496-500.

PMID:
15914750
5.

Anti-Neu5Gc and anti-non-Neu5Gc antibodies in healthy humans.

Gao B, Long C, Lee W, Zhang Z, Gao X, Landsittel D, Ezzelarab M, Ayares D, Huang Y, Cooper DKC, Wang Y, Hara H.

PLoS One. 2017 Jul 17;12(7):e0180768. doi: 10.1371/journal.pone.0180768. eCollection 2017.

6.

Activation of MSRV-type endogenous retroviruses during infectious mononucleosis and Epstein-Barr virus latency: the missing link with multiple sclerosis?

Mameli G, Madeddu G, Mei A, Uleri E, Poddighe L, Delogu LG, Maida I, Babudieri S, Serra C, Manetti R, Mura MS, Dolei A.

PLoS One. 2013 Nov 13;8(11):e78474. doi: 10.1371/journal.pone.0078474. eCollection 2013.

7.

Decreased T cell reactivity to Epstein-Barr virus infected lymphoblastoid cell lines in multiple sclerosis.

Pender MP, Csurhes PA, Lenarczyk A, Pfluger CM, Burrows SR.

J Neurol Neurosurg Psychiatry. 2009 May;80(5):498-505. doi: 10.1136/jnnp.2008.161018. Epub 2008 Nov 17.

8.

Epstein-Barr virus in multiple sclerosis.

Abdelrahman HS, Selim HS, Hashish MH, Sultan LI.

J Egypt Public Health Assoc. 2014 Aug;89(2):90-5. doi: 10.1097/01.EPX.0000452287.65133.fc.

PMID:
25162741
9.

Evaluation of reactive Epstein-Barr Virus (EBV) in Iranian patient with different subtypes of multiple sclerosis (MS).

Ramroodi N, Niazi AA, Sanadgol N, Ganjali Z, Sarabandi V.

Braz J Infect Dis. 2013 Mar-Apr;17(2):156-63. doi: 10.1016/j.bjid.2012.09.008. Epub 2013 Mar 5.

10.

The Correlation between the Virus- and Brain Antigen-Specific B Cell Response in the Blood of Patients with Multiple Sclerosis.

Wunsch M, Hohmann C, Milles B, Rostermund C, Lehmann PV, Schroeter M, Bayas A, Ulzheimer J, Mäurer M, Ergün S, Kuerten S.

Viruses. 2016 Apr 23;8(4):105. doi: 10.3390/v8040105.

11.

A role of late Epstein-Barr virus infection in multiple sclerosis.

Haahr S, Plesner AM, Vestergaard BF, Höllsberg P.

Acta Neurol Scand. 2004 Apr;109(4):270-5.

PMID:
15016009
12.

Abnormally high levels of anti-collagen type IV IgG antibodies in the serum of patients with a clinically isolated syndrome correlate with an increased risk of conversion to MS.

Sadarzanska-Terzieva B, Tzvetanov P, Hegde V, Al-Hashel JY, Rousseff RТ, Haralanov L, Stamenov B, Atanassova M, Marinova I, Marinova A, Rousseva A.

Clin Neurol Neurosurg. 2015 Jun;133:30-3. doi: 10.1016/j.clineuro.2015.03.011. Epub 2015 Mar 17.

PMID:
25837238
13.

Missing links in multiple sclerosis etiology. A working connecting hypothesis.

Soulillou JP.

Med Hypotheses. 2013 May;80(5):509-16. doi: 10.1016/j.mehy.2013.01.036. Epub 2013 Mar 5. Erratum in: Med Hypotheses. 2013 Aug;81(2):366.

PMID:
23466062
14.

Epstein-Barr virus in pediatric multiple sclerosis.

Alotaibi S, Kennedy J, Tellier R, Stephens D, Banwell B.

JAMA. 2004 Apr 21;291(15):1875-9.

PMID:
15100207
15.

Intrathecal CD8 T-cells of multiple sclerosis patients recognize lytic Epstein-Barr virus proteins.

van Nierop GP, Mautner J, Mitterreiter JG, Hintzen RQ, Verjans GM.

Mult Scler. 2016 Mar;22(3):279-91. doi: 10.1177/1352458515588581. Epub 2015 Jun 3.

PMID:
26041797
16.

Exposure to infant siblings during early life and risk of multiple sclerosis.

Ponsonby AL, van der Mei I, Dwyer T, Blizzard L, Taylor B, Kemp A, Simmons R, Kilpatrick T.

JAMA. 2005 Jan 26;293(4):463-9.

PMID:
15671431
17.

Increased CD8+ T cell response to Epstein-Barr virus lytic antigens in the active phase of multiple sclerosis.

Angelini DF, Serafini B, Piras E, Severa M, Coccia EM, Rosicarelli B, Ruggieri S, Gasperini C, Buttari F, Centonze D, Mechelli R, Salvetti M, Borsellino G, Aloisi F, Battistini L.

PLoS Pathog. 2013;9(4):e1003220. doi: 10.1371/journal.ppat.1003220. Epub 2013 Apr 11.

18.

Serological profiling of the EBV immune response in Chronic Fatigue Syndrome using a peptide microarray.

Loebel M, Eckey M, Sotzny F, Hahn E, Bauer S, Grabowski P, Zerweck J, Holenya P, Hanitsch LG, Wittke K, Borchmann P, Rüffer JU, Hiepe F, Ruprecht K, Behrends U, Meindl C, Volk HD, Reimer U, Scheibenbogen C.

PLoS One. 2017 Jun 12;12(6):e0179124. doi: 10.1371/journal.pone.0179124. eCollection 2017.

19.

Epstein-Barr virus in multiple sclerosis.

Bagert BA.

Curr Neurol Neurosci Rep. 2009 Sep;9(5):405-10. Review.

PMID:
19664371

Supplemental Content

Support Center